AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial
2024 · The Lancet · 277 citations
https://doi.org/10.1016/s0140-6736(23)02874-x
Y
Yuxin Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
1.2K
Citations
17
h-index
22
i10-index
Yuxin Chen is an academic researcher from Shandong University. The author has contributed to research in topics: Hearing, Cochlea, Tinnitus, Genetics & RNA regulation and disease & CRISPR and Genetic Engineering. The author has an h-index of 17, co-authored 42 publications.
ORCID: 0009-0004-6241-6535Papers by this author
worksBilateral gene therapy in children with autosomal recessive deafness 9: single-arm trial results
2024 · Nature Medicine · 108 citations
https://doi.org/10.1038/s41591-024-03023-5
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors
2024 · Cell · 69 citations
https://doi.org/10.1016/j.cell.2024.06.013
Precise detection of CRISPR-Cas9 editing in hair cells in the treatment of autosomal dominant hearing loss
2022 · Molecular Therapy — Nucleic Acids · 50 citations
https://doi.org/10.1016/j.omtn.2022.07.016
Advances and challenges in neuroimaging-based pain biomarkers
2024 · Cell Reports Medicine · 28 citations
https://doi.org/10.1016/j.xcrm.2024.101784
NMDA GluN2C/2D receptors contribute to synaptic regulation and plasticity in the anterior cingulate cortex of adult mice
2021 · Molecular Brain · 18 citations
https://doi.org/10.1186/s13041-021-00744-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat